| Literature DB >> 32416746 |
Zhixiao Xu1, Na Li2, Yaqiong Guo2, Yaoyu Feng1,2, Lihua Xiao2.
Abstract
The three common intestinal Cryptosporidium species in cattle differ significantly in host range, pathogenicity and public health significance. While Cryptosporidium parvum is pathogenic in pre-weaned calves and has a broad host range, C. bovis and C. ryanae are largely non-pathogenic and bovine-specific species in post-weaned calves. Thus far, only the genome of C. parvum has been sequenced. To improve our understanding of the genetic determinants of biological differences among Cryptosporidium spcies, we sequenced the genomes of C. bovis and C. ryanae and conducted a comparative genomics analysis. The genome of C. bovis has a gene content and organization more similar to C. ryanae than to other Cryptosporidium species sequenced to date; the level of similarity in amino acid and nucleotide sequences between the two species is 75.2 and 69.4 %, respectively. A total of 3723 and 3711 putative protein-encoding genes were identified in the genomes of C. bovis and C. ryanae, respectively, which are fewer than the 3981 in C. parvum. Metabolism is similar among the three species, although energy production pathways are further reduced in C. bovis and C. ryanae. Compared with C. parvum, C. bovis and C. ryanae have lost 14 genes encoding mucin-type glycoproteins and three for insulinase-like proteases. Other gene gains and losses in the two bovine-specific and non-pathogenic species also involve the secretory pathogenesis determinants (SPDs); they have lost all genes encoding MEDLE, FLGN and SKSR proteins, and two of the three genes for NFDQ proteins, but have more genes encoding secreted WYLE proteins, secreted leucine-rich proteins and GPI-anchored adhesin PGA18. The only major difference between C. bovis and C. ryanae is in nucleotide metabolism. In addition, half of the highly divergent genes between C. bovis and C. ryanae encode secreted or membrane-bound proteins. Therefore, C. bovis and C. ryanae have gene organization and metabolic pathways similar to C. parvum, but have lost some invasion-associated mucin glycoproteins, insulinase-like proteases, MEDLE secretory proteins and other SPDs. The multiple gene families under positive selection, such as helicase-associated domains, AMP-binding domains, protein kinases, mucins, insulinases and TRAPs could contribute to differences in host specificity and pathogenicity between C. parvum and C. bovis. Biological studies should be conducted to assess the contribution of these copy number variations to the narrow host range and reduced pathogenicity of C. bovis and C. ryanae.Entities:
Keywords: Cryptosporidium bovis; Cryptosporidium ryanae; comparative genomics; host specificity; pathogenicity
Mesh:
Substances:
Year: 2020 PMID: 32416746 PMCID: PMC7371110 DOI: 10.1099/mgen.0.000379
Source DB: PubMed Journal: Microb Genom ISSN: 2057-5858
Genomic features of Cryptosporidium bovis and Cryptosporidium ryanae in comparison with Cryptosporidium parvum and other Cryptosporidium species
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|
|
Total length (Mb) |
9.21 |
9.09 |
9.1 |
9.06 |
8.97 |
9.05 |
8.97 |
9.11 |
9.06 |
8.5 |
|
No. of super contigs |
45 |
135 |
8 |
97 |
57 |
50 |
27 |
55 |
93 |
153 |
|
GC content (%) |
28.4 |
28.5 |
30.3 |
30.1 |
31 |
32 |
30.8 |
30.7 |
32.9 |
24.3 |
|
Nucleotide sequence similarity (%) |
24.8 |
25.6 |
38.6 |
38.7 |
38.4 |
38.4 |
38.5 |
– |
69.4 |
40.9 |
|
No. of genes |
3937 |
3905 |
3981 |
3819 |
3782 |
3783 |
3767 |
3723 |
3711 |
3728 |
|
Total length of CDS (Mb)* |
6.93 |
6.86 |
6.83 |
6.81 |
6.91 |
6.94 |
6.94 |
6.8 |
6.74 |
6.69 |
|
GC content in CDS (%) |
30 |
30.1 |
31.9 |
31.8 |
32.4 |
33.6 |
33 |
31.8 |
33.9 |
25.6 |
|
Amino acid sequence similarity (%) |
46.9 |
46.7 |
55.1 |
54.8 |
54.5 |
54.6 |
54.8 |
– |
75.2 |
57.1 |
|
GC content at third position in codons (%) |
17.8 |
18.1 |
22.5 |
23.5 |
24.1 |
26.9 |
24.5 |
25.4 |
30.2 |
12.6 |
|
Gene density (genes/Mb) |
427.5 |
429.6 |
418.1 |
421.5 |
421.6 |
418 |
420 |
408.7 |
409.6 |
438.6 |
|
Percentage coding (%) |
75.2 |
75.5 |
75 |
75.2 |
77 |
76.7 |
77.4 |
74.6 |
74.4 |
78.7 |
|
No. of genes with intron |
798 |
832 |
163 |
417 |
506 |
515 |
758 |
571 |
602 |
763 |
|
Genes with intron (%) |
20.3 |
21.3 |
4.2 |
10.9 |
13.4 |
13.6 |
20.1 |
15.3 |
16.2 |
20.5 |
|
No. of tRNAs |
45 |
44 |
45 |
45 |
45 |
45 |
45 |
45 |
45 |
46 |
|
No. of tRNAmet |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
|
Proteins with signal peptide |
323 |
309 |
397 |
391 |
397 |
396 |
399 |
366 |
329 |
344 |
|
Proteins with transmembrane domain |
836 |
839 |
832 |
817 |
805 |
793 |
772 |
781 |
774 |
813 |
|
Proteins with GPI anchor |
52 |
47 |
63 |
54 |
55 |
57 |
50 |
62 |
57 |
57 |
*CDS, coding sequences.
Fig. 1.Syntenic relationship and shared orthologous genes among Cryptosporidium species. (a) The syntenic relationship in gene organization among genomes of Cryptosporidium parvum, C. ubiquitum, C. bovis, C. ryanae and C. andersoni. Syntenic blocks (regions with orthologous genes) are connected with lines, with the different colours representing eight chromosomes of C. parvum. (b) Venn diagram of orthologous genes shared by five Cryptosporidium species. Abbreviations of taxa: Cryptosporidium parvum IOWA (Cpa); C. ubiquitum (Cub); C. bovis (Cbo); C. ryanae (Cry); C. andersoni (Can).
Fig. 2.Phylogenetic relationships among Cryptosporidium species. (a) Phylogenetic relationship of Cryptosporidium species based on ML analysis of sequences of 100 single-copy orthologous proteins. (b) Phylogenetic relationship of Cryptosporidium species based on ML analysis of insulinase-like proteases. (c) Phylogenetic relationship of Cryptosporidium species based on ML analysis of TRAP sequences. (d) Phylogenetic relationship of Cryptosporidium species based on ML analysis of mucin-type glycoproteins.
Fig. 3.Protein architecture network of Cryptosporidium bovis, Cryptosporidium ryanae and Cryptosporidium parvum. (a) Protein architecture network based on sequence similarity of all proteins in proteomes of C. bovis (green), C. ryanae (red) and C. parvum (blue). 1, AAA proteins; 2, protein kinase; 3, DEAD; 4, SNF2 family; 5, Ras protein; 6, metallophos; 7, HA2 helicase; 8, ubiquitin-conjugating enzyme; 9, ABC transporter; 10, cyclophilin type peptidyl-prolyl cis-trans isomerase; 11, TRAP; 12, zinc finger C3H1-type domain containing protein. (b) Protein architecture network based on sequence similarity of proteins in proteomes of C. parvum (blue), C. bovis (green) and C. ryanae (red). 1, protein kinase; 2, DEAD; 3, AAA proteins; 4, SNF2 family; 5, Ras protein; 6, ABC transporter; 7, TRAP; 8, DnaJ domain; 9, ubiquitin-conjugating enzyme; 10, WD40; 11, cyclophilin type peptidyl-prolyl cis-trans isomerase; 12 proteasome; A, metallophos; B, HA2 helicase; C, RNA recognition motif; D, minichromosome maintenance; E, inner membrane complex protein; F, DHHC domain; G, HSP60; H, CCCH type domain; J, ankyrin repeat; K, FGLN; L, IDE; M, MEDLE; N, Sec7 domain; O, beta-ketoacyl synthase.
Fig. 4.Mitochondrial metabolism in several Cryptosporidium species. Abbreviations of enzymes: AOX, alternative oxidase; MAT, methionine adenosyl transferase; OGDH, oxoglutarate dehydrogenase complex; MQO, malate quinone oxidoreductase. Abbreviations of metabolites: Q, ubiquinone (coenzyme Q); CoA, coenzyme A; IPP, isopentenyl diphosphate; DMAPP, dimethylallyl diphosphate; FPP, farnesyl diphosphate; PPP, polyprenyl diphosphate. Abbreviations of transporter proteins: OMTP, oxoglutarate/malate transporter protein; AATP, amino acids transporter protein; ACTP, acetyl-CoA transporter protein.
Comparison of essential metabolic pathways among Cryptosporidium species and other common apicomplexan parasites
|
Category |
Metabolic pathway |
Cpar |
Chom |
Cmel |
Cchi |
Cubi |
Cbov |
Crya |
Cbai |
Cand |
Pfal |
Tgon |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Carbohydrate and energy metabolism |
Glycolysis |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
|
Methylcitrate cycle |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
TCA cycle |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ |
+ | |
|
Pentose phosphate pathway |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Shikimate biosynthesis |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Folate biosynthesis |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of pterin |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Galactose metabolism |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Synthesis of starch |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Synthesis of trehalose |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Synthesis of 1,3-beta-glucan |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Conversion between UDP-Glc and UDP-Gal |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Conversion between GDP-Man and GDP-Fuc |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Conversion from UDP-Glc to UDP-GlcA to UDP-Xyl |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
− | |
|
Synthesis of mannitol from fructose |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
− | |
|
Fatty acid biosynthesis in cytosol (FAS I) |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Fatty acid biosynthesis in apicoplast (FAS II) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Fatty acid degradation |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Oxidative phosphorylation (NADH dehydrogenase) |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ | |
|
Oxidative phosphorylation (Complex II) |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ |
+ | |
|
Oxidative phosphorylation (Complex III) |
− |
− |
− |
− |
− |
− |
− |
− |
one sub |
+ |
+ | |
|
Oxidative phosphorylation (Complex IV) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
F-ATPase |
two sub |
two sub |
two sub |
two sub |
two sub |
− |
− |
two sub |
+ |
+ |
+ | |
|
Alternative oxidase (AOX) |
+ |
+ |
+ |
+ |
− |
− |
− |
− |
+ |
− |
− | |
|
Glyoxalase metabolism producing |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of isoprene (MEP/DOXP) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of farnesyl/polyprenyl diphosphate |
+ |
+ |
+ |
+ |
− |
− |
− |
− |
+ |
+ |
+ | |
|
Nucleotide metabolism |
Synthesis of purine rings |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
|
Conversion from IMP to XMP |
+ |
+ |
+ |
+ |
+ |
+ |
− |
− |
− |
+ |
+ | |
|
Conversion from XMP to GMP |
+ |
+ |
− |
− |
− |
+ |
− |
− |
− |
+ |
+ | |
|
Synthesis of pyrimidine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Conversion from uracil to UMP |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ |
+ |
+ |
+ | |
|
Conversion from dCMP to dUMP |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ |
+ |
+ |
+ | |
|
Amino acid metabolism |
Synthesis of alanine from pyruvate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
|
Synthesis of glutamate from nitrite/nitrate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Conversion from glutamate to glutamine |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ | |
|
Synthesis of aspartate from oxaloacetate and glutamate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Conversion from aspartate to asparagine |
+ |
+ |
+ |
+ |
+ |
− |
− |
− |
− |
+ |
+ | |
|
Conversion from glutamate to proline |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Synthesis of serine from glycerate/glycerol phosphate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Conversion from serine to cysteine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Conversion from serine to glycine |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ | |
|
Recycle homocysteine into methionine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of lysine from aspartate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Synthesis of threonine from aspartate |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Synthesis of ornithine from arginine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
− | |
|
Synthesis of ornithine from proline |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of polyamine from ornithine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
− | |
|
Polyamine pathway backward |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
− |
+ | |
|
Degradation of branched-chain amino acids |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Synthesis of tryptophan |
+ |
+ |
− |
+ |
+ |
− |
− |
− |
− |
− |
− | |
|
Aromatic amino acid hydroxylases (AAAH) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Vitamins and others |
Synthesis of ubiquinone (coenzyme Q) |
+ |
+ |
+ |
+ |
− |
− |
− |
− |
+ |
+ |
+ |
|
Synthesis of Fe-S cluster |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ | |
|
Synthesis of haem |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of thiamine (vitamin B1) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
− | |
|
Conversion from thiamine to thiamine pyrophosphate (TPP) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of FMN/FAD from riboflavin |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of pyridoxal phosphate (vitamin B6) |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of NAD(P)+ |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Synthesis of pantothenate from valine |
− |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ | |
|
Synthesis of CoA from pantothenate |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ |
+ | |
|
Synthesis of lipoic acid |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ | |
|
Salvage of lipoic acid in mitochondria |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ |
+ | |
|
Synthesis of porphyrin/cytochrome proteins |
− |
− |
− |
− |
− |
− |
− |
− |
− |
+ |
+ |
Plus symbols denote that these metabolic pathways were identified in this apicomplexan parasite, whereas minus symbols denote that these metabolic pathways were absent. Abbreviations: Cryptosporidium parvum (Cpar); C. hominis (Chom); C. meleagridis (Cmel); Cryptosporidium chipmunk genotype I (Cchi); C. ubiquitum (Cubi); C. bovis (Cbov); C. ryanae (Crya); C. baileyi (Cbai); C. andersoni (Cand); Plasmodium falciparum (Pfal); Toxoplasma gondii (Tgon).
Sub, abbreviation of subunit. One sub means only one subunit of the protein was detected in the species.
Putative transporters in Cryptosporidium species and other common apicomplexan parasites*
|
Substrate |
Cellular location |
Tgon |
Pfal |
Cand |
Cmur |
Cpar |
ChomUde |
Cmel |
Cchi |
Cubi |
Cbov |
Crya |
Cbai |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Hexose |
5 |
2 |
2 |
3 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 | |
|
Triose phosphate |
Plasma/apicoplast membrane |
4 |
4 |
8 |
8 |
8 |
8 |
8 |
7 |
8 |
6 |
7 |
7 |
|
Amino acids |
Plasma membrane |
6 |
1 |
12 |
12 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
10 |
|
Nucleobase/nucleoside |
Plasma membrane |
4 |
4 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
Nucleotide-sugar |
Plasma membrane |
4 |
1 |
2 |
2 |
3 |
3 |
3 |
3 |
3 |
3 |
3 |
2 |
|
Folate/pterine |
Plasma membrane |
7 |
2 |
1 |
1 |
1 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
|
Formate/nitrite |
3 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 | |
|
GABA (aminobutanoate) |
Plasma/mitochondrial membrane |
5 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Acetyl-CoA |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 | |
|
Chloride |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 | |
|
Inorganic phosphate |
1 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 | |
|
Sulfate |
4 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 | |
|
Sodium/potassium/calcium |
9 |
0 |
3 |
3 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 | |
|
Zinc |
4 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 |
2 | |
|
Copper |
3 |
2 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 | |
|
Choline |
Plasma membrane |
2 |
1 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
Cadmium/zinc/cobalt (efflux) |
Plasma membrane |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
1 |
|
Glycerol/water |
Plasma membrane |
2 |
2 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
|
ABC transporter |
Plasma membrane |
24 |
16 |
21 |
21 |
21 |
21 |
21 |
21 |
21 |
22 |
20 |
22 |
|
Mitochondrial carrier |
Mitochondrial membrane |
21 |
14 |
13 |
12 |
9 |
9 |
8 |
8 |
6 |
3 |
4 |
6 |
*The detection of these transporter proteins was based on the Pfam search.
Tgon: Toxoplasma gondii; Pfal: Plasmodium falciparum; Cand: Cryptosporidium andersoni; Cmur: C. muris; Cpar: C. parvum; ChomUde: C. hominis UdeA01; Cmel: C. meleagridis; Cchi: Cryptosporidium chipmunk genotype I; Cubi: C. ubiquitum; Cbov: C. bovis; Crya: C. ryanae; Cbai: C. baileyi.
Fig. 5.Selective pressure in multigene families between Cryptosporidium parvum and Cryptosporidium bovis and between C. bovis and Cryptosporidium ryanae as indicated by the dN/dS ratio.
Multigene protein families under positive selective pressure between Cryptosporidium bovis and Cryptosporidium ryanae
|
Gene family |
Gene in |
Gene in |
dN/dS ratio |
Annotation |
|---|---|---|---|---|
|
Helicase |
|
|
1.64629 |
SNF2 helicase |
|
|
|
1.64629 |
Pre-mRNA splicing factor ATP-dependent RNA helicase | |
|
|
|
1.12968 |
SNF2 helicase | |
|
|
|
1.38836 |
Prp16p pre-mRNA splicing factor. HrpA family SFII helicase | |
|
|
|
1.08081 |
SNF2L orthologue with an SWI/SNF2 like ATPase and an Myb domain | |
|
|
|
1.64629 |
PRP43 involved in spliceosome disassembly mRNA splicing | |
|
Insulinase-like peptidase |
|
|
1.73579 |
Secreted insulinase-like peptidase |
|
|
|
1.28419 |
Secreted insulinase-like peptidase | |
|
|
|
1.11455 |
Secreted insulinase-like peptidase | |
|
Protein kinase |
|
|
1.01196 |
Ser/Thr protein kinase |
|
|
|
1.27347 |
Ser/Thr protein kinase | |
|
|
|
1.01594 |
Ser/Thr protein kinase | |
|
|
|
1.17354 |
Ser/Thr protein kinase | |
|
ABC transporter |
|
|
1.80151 |
ABC transporter with 9× transmembrande domains and 2× AAA |
|
|
|
1.19132 |
ABC transporter with 9× transmembrande domains and 2× AAA | |
|
RNA polymerase |
|
|
1.75622 |
RNA polymerase beta subunit |
|
|
|
1.28553 |
DNA-directed RNA polymerase beta subunit | |
|
|
|
1.60633 |
DNA-directed RNA polymerase, possible RNA polymerase | |
|
|
|
1.60829 |
DNA-directed RNA polymerase III C1 subunit | |
|
Acyl transferase domain |
|
|
2.0781 |
Type I fatty acid synthase |
|
|
|
2.03806 |
Polyketide synthase |